Therapeutic effects and associated adverse events of multikinase inhibitors in metastatic renal cell carcinoma: A meta-analysis

Author：

Publisher： Spandidos Publications

E-ISSN： 1792-1015|9|6|2275-2280

ISSN： 1792-0981

Source： Experimental and Therapeutic Medicine, Vol.9, Iss.6, 2015-01, pp. : 2275-2280

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Sunitinib adverse events in metastatic renal cell carcinoma: a meta-analysis

By Ibrahim Ezzeldin Kazkaz Ghieth Abouelkhair Khaled Bayer Ali Elmasri Osama

International Journal of Clinical Oncology, Vol. 18, Iss. 6, 2013-12 ,pp. : 1060-1069

Springer Publishing Company

Access to resources Recommend Favorite

Cruciferous Vegetables Consumption and Risk of Renal Cell Carcinoma: A Meta-Analysis

By Liu Ben Mao Qiqi Wang Xiao Zhou Feng Luo Jindan Wang Chaojun Lin Yiwei Zheng Xiangyi Xie Liping

Nutrition and Cancer, Vol. 65, Iss. 5, 2013-07 ,pp. : 668-676

Routledge Ltd

Access to resources Recommend Favorite

Efficacy of re-challenging metastatic renal cell carcinoma with mTOR inhibitors

By Roca Sophie Quivy Amandine Gross-Goupil Marine Bernhard Jean-Christophe De Clermont Henri Ravaud Alain

Acta Oncologica, Vol. 50, Iss. 7, 2011-10 ,pp. : 1135-1136

Informa Healthcare

Access to resources Recommend Favorite

Sunitinib for metastatic renal cell carcinoma

By Mukherji Deborah Larkin James Pickering Lisa

Future Oncology, Vol. 6, Iss. 9, 2010-09 ,pp. : 1377-1385

Future Medicine

Access to resources Recommend Favorite

Lack of association of microvessel density with prognosis of renal cell carcinoma: evidence from meta-analysis

By Zhang Bing Ji Hong Yan Dongliang Liu Shaoqing Shi Benkang

Tumor Biology, Vol. 35, Iss. 3, 2014-03 ,pp. : 2769-2776

Springer Publishing Company

Access to resources Recommend Favorite